Eisai Co Ltd
Company Profile
Business description
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
Contact
4-6-10 Koishikawa
Bunkyo-ku
Tokyo112-8088
JPNT: +81 338173700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
11,067
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,232.10 | 57.00 | 0.70% |
CAC 40 | 7,536.26 | 33.48 | 0.45% |
DAX 40 | 22,242.45 | 177.94 | 0.81% |
Dow JONES (US) | 40,113.50 | 20.10 | 0.05% |
FTSE 100 | 8,415.25 | 7.81 | 0.09% |
HKSE | 21,980.84 | 0.10 | 0.00% |
NASDAQ | 17,382.94 | 216.90 | 1.26% |
Nikkei 225 | 35,865.34 | 159.60 | 0.45% |
NZX 50 Index | 12,105.64 | 87.80 | 0.73% |
S&P 500 | 5,525.21 | 40.44 | 0.74% |
S&P/ASX 200 | 8,026.40 | 58.20 | 0.73% |
SSE Composite Index | 3,294.02 | 1.04 | -0.03% |